Curriculum Vitae Joshua G. Petrie, PhD

Transcription

1 Curriculum Vitae Joshua G. Petrie, PhD Office: Home: University of Michigan School of Public Health 1415 Washington Heights, M5118 SPH II Ann Arbor, MI Phone: (734) Coleman Street Ypsilanti, MI Cell: (734) Education Ph.D. in Epidemiologic Sciences, University of Michigan School of Public Health, Ann Arbor, MI M.P.H. in Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI B.S. in Biology, University of Michigan, College of Literature, Science and the Arts, Ann Arbor, MI Appointments Research Investigator, Department of Epidemiology Graduate Student Research Assistant, Department of Epidemiology Research Area Specialist Intermediate, Monto/Ohmit Research Group Research Assistant, Monto/Ohmit Research Group Research Technician Associate, Cellular Immunology Core Laboratory University of Michigan Medical School, Ann Arbor, MI Committees and Activities 2016-Present Member International Society for Influenza and Other Respiratory Viruses 2016-Present Journal of Infection and Public Health (ad hoc reviewer) 2015-Present Vaccine (ad hoc reviewer) 2015-Present Epidemiology and Infection (ad hoc reviewer) Epidemiology Doctoral Student Organization, University of Michigan School of Public Health Public Health Action Support Team (PHAST), University of Michigan School of Public Health

2 Teaching and Mentoring Experience Guest Lectures Winter 2016 Efficacy and Effectiveness of Influenza Vaccines. Epidemiology 609: Vaccines in Public Health, University of Michigan School of Public Health Publications 1. Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, Monto AS, McLean HQ, Belongia EA, Gaglani M, Clipper L, Fry AM, Flannery B Influenza vaccine effectiveness in the United States by vaccine type. Clinical Infectious Diseases 2016; Accepted for publication. 2. Petrie JG, Ohmit SE, Cheng CK, Martin ET, Malosh RE, Lauring AS, Lamerato LE, Reyes KC, Flannery B, Ferdinands JM, Monto AS. Influenza vaccine effectiveness against antigenically drifted influenza higher than expected in hospitalized adults: Clinical Infectious Diseases 2016; DOI: /cid/ciw Petrie JG, Ohmit SE, Truscon R, Johnson E, Braun TM, Levine MZ, Eichelberger MC, Monto AS. Modest waning of influenza vaccine efficacy and antibody titers during the influenza season. Journal of Infectious Diseases 2016; DOI: /infdis/jiw Gaglani M, Pruszynski J, Murthy K, Clipper L, Robertson A, Reis M, Chung JR, Piedra PA, Avadhanula V, Nowalk MP, Zimmerman RK, Jackson ML, Jackson LA, Petrie JG, Ohmit SE, Monto AS, McLean HQ, Belongia EA, Fry AM, Flannery B. Influenza vaccine effectiveness against the 2009 pandemic A (H1N1) virus differed by vaccine-type during in the United States. Journal of Infectious Diseases 2016; 213: Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, Nowalk MP, Talbot HK, Treanor JJ, Belongia EA, Murthy K, Jackson LA, Petrie JG, Zimmerman RK, Griffin MR, McLean HQ, Fry AM. Seasonal effectiveness of live attenuated and inactivated influenza vaccine. Pediatrics 2016; 137: Thompson MG, Clippard J, Petrie JG, Jackson ML, McLean HQ, Gaglani M, Reis EC, Flannery B, Monto AS, Jackson L, Belongia EA, Murthy K, Zimmerman RK, Thaker S, Fry AM. Influenza vaccine effectiveness for fully and partially vaccinated children 6 months to 8 years old during and : The importance of two priming doses. Pediatric Infectious Disease Journal 2016; 35: Ohmit SE, Petrie JG, Malosh RE, Johnson E, Truscon R, Aaron B, Martens C, Cheng C, Fry AM, Monto AS. Substantial influenza vaccine effectiveness observed in households with children in a season in which A (ph1n1) predominated ( ). Journal of Infectious Diseases 2016; 213: Petrie JG, Cheng C, Malosh RE, VanWormer JJ, Flannery B, Zimmerman RK, Gaglani M, Jackson ML, King JP, Nowalk MP, Benoit J, Robertson A, Thaker SN, Monto AS, Ohmit SE. Illness severity and work productivity loss among working adults with medically-attended acute respiratory illnesses: US influenza vaccine effectiveness network Clinical Infectious Diseases 2016; 62: Petrie JG, Ohmit SE, Johnson E, Truscon R, Monto AS. Persistence of antibodies to influenza hemagglutinin and neuraminidase following one or two years of influenza vaccination. Journal of Infectious Diseases 2015; 212:

3 10. Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W, Levine M, Katz JM, Ohmit SE. Antibody to the influenza neuraminidase: an independent correlate of protection. Journal of Infectious Diseases 2015; 212: Havers FP, Flannery B, Clippard JR, Gaglani M, Zimmerman RK, Jackson LA, Petrie JG, McLean HQ, Nowalk MP, Jackson ML, Monto AS, Belongia EA, Eng HF, Lamerato L, Campbell AP, Fry AM. Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the influenza season. Clinical Infectious Diseases 2015; 60: Ohmit SE, Petrie JG, Malosh RE, Fry AM, Thompson MG, Monto AS. Influenza vaccine effectiveness in households with children during the season: assessments of prior vaccination and serologic susceptibility. Journal of Infectious Diseases 2015; 211: McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman RK, Nowalk MP, Raviotta JM, Jackson ML, Jackson L, Ohmit SE, Petrie JG, Monto AS, Meece JK, Thaker SN, Clippard JR, Spencer SM, Fry AM, Belongia EA. Influenza vaccine effectiveness in the United States during : variable protection by age and virus type. Journal of Infectious Diseases 2015; 211: Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Petrie JG, McLean HQ, Belongia EA, Gaglani M, Berman L, Foust A, Sessions W, Thaker SN, Spencer S, Fry AM. Early estimates of seasonal influenza vaccine effectiveness - United States, January MMWR 2015; 64: Monto AS, Malosh RE, Petrie JG, Thompson MG, Ohmit SE. Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over three surveillance seasons. Journal of Infectious Diseases 2014; 210: Havers F, Thaker S, Clippard JR, Jackson M, McLean HQ, Gaglani M, Monto AS, Zimmerman RK, Jackson L, Petrie JG, Nowalk MP, Moehling KK, Flannery B, Thompson MG, Fry AM. Use of influenza antiviral agents by ambulatory care clinicians during the influenza season. Clinical Infectious Diseases 2014; 59: Malosh R, Ohmit SE, Petrie JG, Thompson MG, Aiello AE, Monto AS. Factors associated with influenza vaccine receipt in community dwelling adults and their children. Vaccine 2014; 32: Ohmit SE, Thompson MG, Petrie JG, Thaker SN, Jackson ML, Belongia EA, Zimmerman RK, Gaglani M, Lamerato L, Spencer SM, Jackson L, Meece JK, Nowalk MP, Song J, Zervos M, Cheng PY, Rinaldo CR, Clipper L, Shay DK, Piedra P, Monto AS. Influenza vaccine effectiveness in the season: protection against each circulating virus and the effect of prior vaccination on estimates. Clinical Infectious Diseases 2014; 58: Petrie JG, Ohmit SE, Cowling BJ, Johnson E, Cross RT, Malosh RE, Thompson MG, Monto AS. Influenza transmission in a cohort of households with children: PLoS One 2013; 8:e Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS. Influenza vaccine effectiveness in the community and the household. Clinical Infectious Diseases 2013; 56: Jackson L, Jackson ML, Phillips CH, Benoit J, Belongia EA, Cole D, Kopitzke S, Koepel TAK, McLean HQ, Meece JK, Strey SK, Sundaram ME, Vandermause M, Gaglani M, Song J, Clipper L, Kjar D, Robertson A, Murthy K, Dunnahoo M, Oliver S, Weir M, Gonzales H, Zayed M, Ponder T, Nichols J, Reis M, Rivera C, Morgan D, Piedra P,

4 Avadhanula V, Monto AS, Ohmit SE, Petrie JG, Johnson E, Cross RT, Martens C, Zervos M, Lamerato L, Aubuchon MA, Wolff GG, Eng H, Nowalk MP, Wisniewski SR, Zimmerman RK, Rinaldo CR, Bullotta A, Suyama J, Reis E, Middleton DB, Hess R, Thompson MG, Fry AM, Thaker SN, Ferdinands J, Cheng PY, Spencer S, Burns E, Berman L, Sessions W, Foust A, Bresee J, Cox N. Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States February MMWR 2013; 62: Jackson L, Jackson ML, Phillips CH, Benoit J, Belongia EA, Cole D, Kopitzke S, Koepel TAK, McLean HQ, Meece JK, Strey SK, Sundaram ME, Vandermause M, Gaglani M, Song J, Clipper L, Kjar D, Robertson A, Murthy K, Dunnahoo M, Oliver S, Weir M, Gonzales H, Zayed M, Reis M, Rivera C, Morgan D, Piedra P, Avadhanula V, Monto AS, Ohmit SE, Petrie JG, Johnson E, Cross RT, Martens C, Zervos M, Lamerato L, Eng H, Nowalk MP, Wisniewski SR, Zimmerman RK, Rinaldo CR, Bullotta A, Suyama J, Reis E, Middleton DB, Hess R, Thompson M, Fry AM, Thaker SN, Spencer S, Cheng PY, Shay DK, Berman L, Bresee J, Burns E, Tokars J, Cox N. Early estimates of seasonal influenza vaccine effectiveness - United States January MMWR 2013; 62: Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, Shay DK. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clinical Infectious Diseases 2012; 55: Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutinationinhibition antibody titer as a correlate of vaccine-induced protection. Journal of Infectious Diseases 2011; 204; Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Breese Hall C, Williams JV, Gargiullo P, Berman L, Shay DK. Effectiveness of non-adjuvented pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011; 6:e Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. Journal of Infectious Diseases 2011; 203: Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC. Comparative efficacy of inactivated and live attenuated influenza vaccines. New England Journal of Medicine 2009; 361: Presentations Petrie JG*, Cheng CK, Malosh RE, Martin ET, Fry AM, Monto AS. No evidence of influenza vaccine effectiveness against antigenically drifted influenza A (H3N2) viruses in a household cohort during the influenza season. IDWeek. October 27, New Orleans, LA. Poster Presentation 799. Petrie JG*, Eisenberg MC, Ng S, Malosh RE, Lee KH, Ohmit SE, Monto AS. Application of an individual based transmission hazard model for estimation of influenza vaccine effectiveness in a household cohort. Options IX for the Control of Influenza. August 25, Chicago, IL. Poster Presentation P-109. Petrie JG*, Parkhouse K, Ohmit SE, Monto AS, Hensley SE. Influenza A (ph1n1) susceptibility can be predicted by standard hemagglutination-inhibition assays

5 using contemporary A (ph1n1) viral strains. Options IX for the Control of Influenza. August 25, Chicago, IL. Poster Presentation P-134. Petrie JG*, Ohmit SE, Martin ET, Malosh RE, Cheng CK, Lauring AS, Lamerato L, Reyes KC, Lipkovich H, Flannery B, Ferdinands JM, Monto AS. Influenza vaccine effectiveness against antigenically drifted influenza higher than expected in hospitalized adults: IDWeek. October 10, San Diego, CA. Oral Abstract LB-9. Petrie JG*, Ohmit SE, Monto AS. Waning influenza vaccine efficacy during the influenza season. IDWeek. October 10, San Diego, CA. Poster Presentation Fry AM, Gubareva L, Garten R, Clippard J, Mishin V, Spencer S, Thaker S, Nowalk MP, Jackson ML, Jackson LA, Monto A, Zimmerman RK, Petrie JG, Belongia E, Mclean HQ, Gaglani M, Piedra P, Barnes JR, Xiyan X, Flannery B. Influenza vaccine effectiveness against drifted versus vaccine-like A/H3N2 viruses during the influenza season US Flu VE Network. IDWeek. October 10, San Diego, CA. Oral Abstract Havers F, Hicks L, Clippard J, Gaglani M, Zimmerman RK, Jackson ML, Petrie JG, Mclean HQ, Nowalk MP, Monto A, Belongia E, Eng H, Flannery B, Fry AM. Outpatient antibiotic prescribing for acute respiratory illnesses including influenza during the influenza season. IDWeek. October 10, San Diego, CA. Oral Abstract Martin ET, Evans R, Archer C, Petrie JG, Arshad S, Kaye KS. Influenza, obesity and timely administration of oseltamivir: a prospective study of patient outcomes. IDWeek. October 8, San Diego, CA. Poster Presentation 495. Petrie JG*, Ohmit SE, Cross R, Monto AS. Persistence of antibody to influenza hemagglutinin over two influenza seasons. IDWeek. October 9, Philadelphia, PA. Oral Abstract 533. Petrie JG*, Ohmit SE, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS. Influenza vaccine effectiveness in the community and the household. IDWeek. October 20, San Diego, CA. Poster Presentation Petrie JG*, Ohmit SE, Malosh RE, Monto AS. Influenza Vaccine Effectiveness in Households with Children. Michigan Epidemiology Conference. March 30, 2012, East Lansing, MI. Poster presentation. Petrie JG*, Ohmit SE, Monto AS. Severity and duration of influenza illness among vaccine failures. Michigan Epidemiology Conference. April 3, 2008, East Lansing, MI. Poster presentation. * Presenting Author Research Support Ongoing U01 IP (PIs: Monto, Martin) Source: CDC $6,499,995 08/01/ /31/2021 Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States Major Goals: This cooperative agreement is intended to determine, on an annual basis, the effectiveness of influenza vaccine by collecting and comparing data on

6 laboratory confirmed outpatient influenza cases and controls. Household cohort study funded as an optional components. Role: Co-Investigator U01 IP (PIs: Monto, Martin) Source: CDC $2,633,336 08/01/ /31/2020 US Platform to Measure Influenza Vaccine Effectiveness Against Laboratory-confirmed Influenza-associated Hospitalizations Major Goals: This cooperative agreement is intended to determine, on an annual basis, the effectiveness of influenza vaccine in hospitalized patients by collecting and comparing data on laboratory confirmed hospitalized influenza cases and controls. Role: Co-Investigator, Graduate Student Research Assistant R01 AI (PIs: Monto, Ohmit) Source: NIAID $2,545,091 08/20/ /31/2017 Household Studies of Influenza and Other Respiratory Viruses Major Goals: This grant allows expansion of a household cohort study of influenza vaccine effectiveness to include identification of other respiratory viruses and analysis of immunologic responses to influenza infection and vaccination. Role: Co-Investigator, Graduate Student Research Assistant, Project Manager Completed U01 IP (PIs: Monto, Ohmit) Source: CDC $6,213,785 07/01/ /31/2016 Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Medically Attended and Non-medically Attended Outcomes Major Goals: This cooperative agreement is intended to determine, on an annual basis, the effectiveness of influenza vaccine by collecting and comparing data on laboratory confirmed outpatient influenza cases and controls. Household cohort and inpatient studies funded as an optional components. Role: Graduate Student Research Assistant, Project Manager Selected Training and Workshops Summer Institute in Statistics and Modeling in Infectious Disease (SISMID) July 9-16, University of Washington